Concepedia

Publication | Closed Access

Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.

26

Citations

0

References

2001

Year

Michael Hejna, Gerhard Hamilton, T. Brodowicz, I Haberl, Wolfgang Fiebiger, Werner Scheithauer, Irene Virgolini, Wolfgang J. Köstler, Georg Oberhuber, Markus Raderer
PubMed

Abstract

As opposed to pancreatic cancer and healthy controls, patients in our series had elevated serum VIP-levels. Further studies are warranted to evaluate whether VIP can be used as a tumor marker in this disease.